IP Library Granted Patent US 7,217,728
Granted Patent B2
US 7,217,728 · App. 10/945,650 · Granted May 15, 2007

Diaminopropionic acid derivatives

Assignee: Hoffmann-La Roche Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,217,728
App. No.
10/945,650
Granted
May 15, 2007
Kind
B2
Abstract

A compound of formula 1a which is useful for treating reperfusion injury, and salts, prodrugs, and related compounds.

Claims (51)

1. A compound of formula:

wherein R 1 is a group of the formula

where A is hydrogen, hydroxy, amino, or halogen and B is amino, carboxy, hydrogen, hydroxy, cyano, trifluoromethyl, halogen, lower alkyl, or lower alkoxy; R 2 is a group of the formula

where R 3 is hydrogen, carboxy, or lower alkyl;

n is 0 or 1;

U, V, and W are independently hydrogen, halogen, or lower alkyl provided U and V are not both hydrogen;

X is carbonyl, phenyl-substituted loweralkylene, or sulfonyl;

Y is lower alkylene which may be substituted with one or more of amino, substituted amino, lower alkyl, or cyclo lower alkyl, or Y is lower alkenylene or lower alkylenethio; and k is 0 or 1;

when k is 1:

Z is hydrogen, lower alkylthio, —COOH, —CONH 2 , or amino, or when k is 0 or 1, Z is: 1-adamantyl, diphenylmethyl, 3-[[(5-chloropyridin-2-yl)amino]carbonyl]pyrazin-2-yl, hydroxy, phenylmethoxy, 2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]phenyl, [(2,6-dichlorophenyl)methoxy]phenyl, or Z is one of the following:

cycloalkyl or aryl containing 0 to 3 heteroatoms which may be the same or different, or a fused ring system containing two or three rings which rings are independently cycloalkyl or aryl containing 0 to 3 heteroatoms which may be the same or different, any of which rings may be unsubstituted, or substituted with at least one of:

halogen, cyano, amino, substituted amino, aminosulfonyl, nitro, oxo, hydroxy, aryl, aryloxy, unsubstituted lower alkyl, halogen-substituted lower alkyl, lower alkoxy-substituted lower alkyl, lower alkoxy, lower alkanesulfonyl, lower alkylthio, acetyl, aminocarbonyl, hydrazino, carboxy, lower alkoxycarbonyl, acetoxy or amino loweralkyl;

or a pharmaceutically acceptable salts and esters thereof.

2. A compound of claim 1 wherein Z is thiophene, furan, thiazole, cyclopentyl, cyclohexyl, piperidine, pyridine, naphthalene, benzothiophene, benzothiazole, 1,4-dioxa-8-thiaspiro[4,5]decyl, phenyl, or phenyl substituted by one or more of lower alkoxy, lower alkyl, chlorine, bromine, fluorine, hydroxy, nitro, cyano, amino, substituted amino, aminosulfonyl, alkoxycarbonyl, trifluoromethyl, or carboxy.

3. A compound of claim 1 wherein A, when present, is hydroxy, hydrogen, or amino and B is hydrogen or hydroxy; W is hydrogen and at least one of U and V are methyl or halogen, k is 0 or Y is lower alkylene; and Z is hydrogen, phenyl, thiophene, furan, pyrrole, pyrazole, imidazole, thiazole, or isoxazole or a six-membered aromatic ring with one to three nitrogens any of which may be unsubstituted or substituted with at least one of:

halogen, hydroxy, lower alkoxy, nitro, amino, substituted amino, cyano, carboxy, trifluoromethyl, lower alkyl, aminosulfonyl, or lower alkoxycarbonyl.

4. A compound of claim 1 having formula

wherein R 1 is a group of the formula

at least one of U and V are chlorine, bromine, or methyl; k is 0 or Y is butylene; X is carbonyl, phenyl-substituted lower alkylene, or sulfonyl; and Z is hydrogen, phenyl, thiazole, or thiophene, or Z is phenyl, thiazole, or thiophene substituted with at least one of methyl or acetylamino.

5. A compound of claim 4 wherein R 3 is hydrogen.

6. Compounds of claim 5 which are:

3-(benzoylamino)-N-[2-chloro-4-[[(2,3-dihydro-2-oxo-1H-indol-4-ylmethyl)aminocarbonyl]benzoyl]-L-alanine;

3-(benzoylamino)-N-[2-chloro-4-[[(1H-indol-4-ylmethyl)aminocarbonyl]benzoyl]-L-alanine;

N-[2-chloro-4-[[(1H-benzimidazol-4-ylmethyl)aminocarbonyl]benzoyl]-3-(thiophene-2-carbonyl)amino-L-alanine;

N-[2-chloro-4-[[(1H-indol-4-ylmethyl)aminocarbonyl]benzoyl]-3-(thiophene-2-carbonyl)amino-L-alanine;

N-[2-chloro-4-[[(2,3-dihydro-1H-indol-4-ylmethyl)aminocarbonyl]benzoyl]-3-(thiophene-2-carbonyl)amino-L-alanine;

N-[2-bromo-4-[[(1H-indol-4-ylmethyl)amino]carbonyl]benzoyl]-3-(thiophene-2-carbonyl)amino-L-alanine;

N-[2-chloro-4-[[(1H-indol-4-ylmethyl)amino]carbonyl]benzoyl]-3-(thiophene-3-carbonyl)amino-L-alanine;

N-[2-chloro-4-[[(1H-indol-4-ylmethyl)amino]carbonyl]benzoyl]-3-(5-methylthiophene-2-carbonyl)amino-L-alanine; and

N-[2-chloro-4-[[[(1H-indazol-4-yl)methyl]amino]carbonyl]benzoyl]-3-(thiophene-2-carbonyl)amino-L-alanine.

7. A compound of claim 4 wherein R 3 is methyl.

8. A compound of formula:

wherein R 1 is a group of the formula

where A is hydrogen, hydroxy, amino, or halogen and B is amino, carboxy, hydrogen, hydroxy, cyano, trifluoromethyl, halogen, lower alkyl, or lower alkoxy; R 2 is a group of the formula

where R 3 is hydrogen, carboxy, or lower alkyl;

n is 0 or 1;

U, V, and W are independently hydrogen, halogen, or lower alkyl provided U and V are not both hydrogen;

X is carbonyl, phenyl-substituted loweralkylene, or sulfonyl;

Y is lower alkylene which may be substituted by one or more of amino, substituted amino, loweralkyl, or cyclo lower alkyl, or Y is lower alkenylene or lower alkylenethio; k is 0 or 1;

when k is 1, Z is:

hydrogen, lower alkylthio, —COOH, —CONH 2 , or amino, or when k is 0 or 1, Z is: 1-adamantyl, diphenylmethyl, 3-[[(5-chloropyridin-2-yl)amino]carbonyl]pyrazin-2-yl, hydroxy, phenylmethoxy, 2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]-carbonyl]phenyl, [(2,6-dichlorophenyl)methoxy]phenyl, or Z is one of the following:

cycloalkyl or aryl containing 0 to 3 heteroatoms which may be the same or different, or a fused ring system containing two or three rings which rings are independently cycloalkyl or aryl containing 0 to 3 heteroatoms which may be the same or different, any of which rings may be unsubstituted, or substituted with at least one of:

halogen, cyano, amino, substituted amino, aminosulfonyl, nitro, oxo, hydroxy, aryl, aryloxy, unsubstituted lower alkyl, halogen-substituted lower alkyl, lower alkoxy-substituted lower alkyl, lower alkoxy, lower alkanesulfonyl, lower alkylthio, acetyl, aminocarbonyl, hydrazino, carboxy, lower alkoxycarbonyl, acetoxy, or amino loweralkyl;

R 6 is lower alkyl or —CH 2 CH 2 —R 7 where R 7 is —N(CH 3 ) 2 ,

where R 8 is hydrogen or methyl and R 9 is lower alkyl or lower cycloalkyl; and pharmaceutically acceptable salts and esters thereof.

9. A compound of claim 8 wherein R 6 is ethyl.

10. A compound of claim 8 wherein R 6 is CH 2 CH 2 —R 7 .

11. A compound of claim 10 wherein R 7 is —N(CH 3 ) 2 ,

12. A compound of claim 8 wherein R 6 is

13. A compound of claim 12 wherein R 8 is hydrogen or methyl.

14. A compound of claim 12 wherein R 9 is ethyl or cyclohexyl.

Continuity (5)
Division 1034928900 · Jan 22, 2003
Division 0987970000 · Jun 12, 2001
Division 0940753400 · Sep 29, 1999
Provisional Application 6010412000 · Oct 13, 1998
Related Publication 20050080119A1 · Apr 14, 2005